Table 6.

Major bleeding complications of the subgroups of patients with diabetes

Event	Single-agent (n = 2562)	Multiagent or insulin (n = 5683)	P value
Major bleeding complications, n (%)	50 (2.0%)	204 (3.6%)	<0.001
RBC transfusion, n (%)	49 (1.9%)	192 (3.4%)	<0.001
Invasive hemostasis, n (%)	2 (0.1%)	25 (0.4%)	0.008
Massive RBC transfusion, n (%)	7 (0.3%)	124 (2.2%)	<0.001

RBC, red blood cell.

Some patients received both RBC transfusion and invasive hemostasis. Thus, they were not mutually exclusive.